 "Sun Pharma stock up on US court's ruling")
[caption id="" align=“alignleft” width=“380” caption=“Reuters”][/caption]
Sun Pharmaceutical Industries rose 2.4 percent after the US Supreme Court allowed the Indian drug maker to sue a brand name rival in a bid to develop a generic diabetes drug for the US market.
Caraco Pharmaceuticals, a unit of Sun, had argued the patent description for Prandin, a diabetes drug developed by Denmark’s Novo Nordisk, was too broad, and effectively prevented generic versions to hit the market.
STORY CONTINUES BELOW THIS AD
Analysts say that Sun Pharma is now more likely to be able to launch a generic version of Prandin, probably by fiscal 2013.
Reuters
End of Article
 "Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty")
 "Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched")
 "Who is CP Radhakrishnan, India's next vice-president?")
 "Israel informed US ahead of strikes on Hamas leaders in Doha, says White House")
 "Israel targets top Hamas leaders in Doha; Qatar, Iran condemn strike as violation of sovereignty")
 "Nepal: Oli to continue until new PM is sworn in, nation on edge as all branches of govt torched")
 "Who is CP Radhakrishnan, India's next vice-president?")
 "Israel informed US ahead of strikes on Hamas leaders in Doha, says White House")
